Efficacy of exemestane, a new generation of aromatase inhibitor, on sex differentiation in a gonochoristic fish.
We report the first use of exemestane (EM), a steroidal aromatase inhibitor (AI) commercially known as aromasin, in studies of sex differentiation in fish. The effectiveness of EM was examined in two different age groups of the gonochoristic fish, Nile tilapia (Oreochromis niloticus). Untreated control fish (all female) showed normal ovarian differentiation through 120 days after hatching (dah), whereas fish treated with EM at 1000 and 2000 microg/g of feed from 9 dah through 35 dah, the critical period for sex differentiation, exhibited complete testicular differentiation; all stages of spermatogenic germ cells were evident and well developed efferent ducts were present. Fish treated with EM at 1000 microg/g of feed from 70 dah through 100 dah significantly suppressed plasma estradiol-17beta level and increased level of 11-ketotestosterone. Furthermore, untreated control fish showed strong gonadal expression of the steroidogenic enzymes P450 cholesterol-side chain-cleavage enzyme (P450scc), 3beta-hydroxysteroid dehydrogenase (3beta-HSD), and cytochrome P450 aromatase (P450arom). In contrast, EM-treated fish showed immunopositive reactions against P450scc and 3beta-HSD but not against P450arom in interstitial Leydig cells. These results indicate that treatment of tilapia juveniles with EM during sex differentiation leads to the development of testes, apparently by a complete suppression of aromatase activity.
Ruksana
Sabina
S
Sesoko Station, Tropical Biosphere Research Center, University of the Ryukyus, Sesoko 3422, Motobu, Okinawa 905-0227, Japan.
Pandit
Narayan P
NP
Nakamura
Masaru
M
D000730:Androstadienes / Q000633:toxicity*; D000818:Animals; D047072:Aromatase Inhibitors / Q000633:toxicity*; D023681:Cichlids / Q000254:growth & development*; D005260:Female; D006066:Gonads / Q000002:abnormalities* / Q000187:drug effects* / Q000201:enzymology; D008297:Male; D012733:Sex Differentiation / Q000187:drug effects* / Q000502:physiology
D000730:Androstadienes; D047072:Aromatase Inhibitors; C056516:exemestane